CS logo
small CS logo
Lovelace Medical Center at Lovelace Sandia Health System

Albuquerque, New Mexico, United States
Hospital in Albuquerque, New Mexico
601 Dr Martin Luther King Jr Ave NE, Albuquerque, NM 87102

About Lovelace Medical Center at Lovelace Sandia Health System


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Lovelace Medical Center at Lovelace Sandia Health System


During the past decade, Lovelace Medical Center at Lovelace Sandia Health System conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Lovelace Medical Center at Lovelace Sandia Health System" #1 sponsor was "Radiation Therapy Oncology Group" with 5 trials, followed by "New Mexico Cancer Care Alliance" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "GlaxoSmithKline" with 1 trials sponsored and "Heart Rhythm Clinical and Research Solutions, LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lovelace Medical Center at Lovelace Sandia Health System" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

Clinical Trials Conditions at Lovelace Medical Center at Lovelace Sandia Health System


According to Clinical.Site data, the most researched conditions in "Lovelace Medical Center at Lovelace Sandia Health System" are "Cancer" (4 trials), "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Alzheimer's Disease" (1 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "Lovelace Medical Center at Lovelace Sandia Health System" in a lesser frequency.

Clinical Trials Intervention Types at Lovelace Medical Center at Lovelace Sandia Health System


Most popular intervention types in "Lovelace Medical Center at Lovelace Sandia Health System" are "Drug" (13 trials), "Radiation" (5 trials), "Biological" (2 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (4 trials), "cisplatin" (3 trials), "fluorouracil" (3 trials), "celecoxib" (2 trials) and "5-Flourouracil, Interferon-a, IL-2 and Thalidomide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Lovelace Medical Center at Lovelace Sandia Health System


The vast majority of trials in "Lovelace Medical Center at Lovelace Sandia Health System" are 15 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Lovelace Medical Center at Lovelace Sandia Health System


Currently, there are NaN active trials in "Lovelace Medical Center at Lovelace Sandia Health System". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Lovelace Medical Center at Lovelace Sandia Health System, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Lovelace Medical Center at Lovelace Sandia Health System, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".